JPET Celsis microsomes equal better data

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by DEMPSEY, P. J.
Right arrow Articles by COOPER, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by DEMPSEY, P. J.
Right arrow Articles by COOPER, T.
Journal of Pharmacology And Experimental Therapeutics, Vol. 167, Issue 2, 282-290, 1969
Copyright © 1969 by American Society for Pharmacology and Experimental Therapeutics


VENTRICULAR CHOLINERGIC RECEPTOR SYSTEMS: INTERACTION WITH ADRENERGIC SYSTEMS

PETER J. DEMPSEY 1 and THEODORE COOPER 1

1 National Heart Institute, Bethesda, Maryland

It has been demonstrated in several cardiac preparations that acetylcholine (ACh) may exert various effects upon the chronotropic and inotropic state of ventricular myocardium. In high doses ACh will cause a catecholamine-mediated positive inotropic response, but it will also antagonize other catecholamine-mediated metabolic effects on heart preparations. Mechanisms underlying the various cardiac effects of ACh were examined in isolated cat hearts (20 normal; 14 catecholamine depleted) perfused with a modified Krebs' solution and electrically paced. Maximum pressure developed in the isovolumically beating left ventricle was used as an index of contractility. In normal hearts ACh depressed contractility in doses of 10-6 g to 10-5 g; higher doses produced a positive inotropic effect which could be blocked by dl-propranolol or d-tubocurarine. A positive inotropic dose of ACh given prior to an equipotent dose of norepinephrine blocked the inotropic response to norepinephrine for 3 to 4 min. The administration of atropine to normal hearts shifted the dose-response curve for the ACh-mediated positive inotropic response to the left, and prevented inhibition of the response to norepinephrine by ACh. In catecholamine-depleted hearts only the negative inotropic effect of ACh was seen. However, the administration of ACh prior to norepinephrine still inhibited the norepinephrine response. These observations: 1) confirm previous reports of an ACh-norepinephrine antagonism on ventricular muscle; 2) indicate that the "nicotinic" action of ACh is not involved in this antagonism; and 3) demonstrate the time sequence and des-dependent nature of this phenomenon.

Submitted on August 15, 1968
Accepted on February 26, 1969







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1969 by the American Society for Pharmacology and Experimental Therapeutics.